Eco-friendly spectrophotometric quantification of the potential combination of mirabegron and tamsulosin. [PDF]
Sci RepEl-Abassy OM +3 more
europepmc +1 more source
β<sub>3</sub>-Adrenoceptor Agonist Effects on the Urinary Bladder Beyond Detrusor Relaxation. [PDF]
Neurourol UrodynMichel MC, Arioglu-Inan E, Hennenberg M.
europepmc +1 more source
Green HPLC technique development for the simultaneous determination of the potential combination of Mirabegron and Tamsulosin. [PDF]
Sci RepBahgat EA +3 more
europepmc +1 more source
A randomized controlled trial study on effectiveness between tadalafil versus combination mirabegron and solifenacin on treatment of ureteral stent-related symptoms. [PDF]
Pan Afr Med J, 2023 Ciayadi TA +6 more
europepmc +1 more source
A comparative study of mirabegron versus doxazosin in improving ureteral stent-related dysfunction. [PDF]
World J UrolTao B +5 more
europepmc +1 more source
Urinary beta 3-adrenoceptor as a diagnostic biomarker for overactive bladder in women. [PDF]
Sci Rep, 2023 Liang CC +6 more
europepmc +1 more source
Sustainable UV approaches backed by one step extraction procedure for quantifying the newly released mirabegron and silodosin mixture in urine. [PDF]
Sci RepMohamed AR, El-Hanboushy S, Darweish E.
europepmc +1 more source
The Efficacy and Safety Between Intradetrusor OnabotulinumtoxinA Injection and Combined Pharmacotherapy in Patients With Refractory Overactive Bladder: A Randomized Controlled Trial. [PDF]
J UrolHsieh MH, Hwang JC, Su TH, Lau HH.
europepmc +1 more source
Efficacy and safety of combination of mirabegron and solifenacin in patients with double-J stent related overactive bladder: a prospective study. [PDF]
Sci Rep, 2022 Tang QL, Zhou S, Liu YQ, Wu J, Tao RZ.
europepmc +1 more source